Malignant Hyperthermia

This is a Stub Notice. This page has not been completed. You can work on this page by signing in and going to the Edit tab. Thanks for helping to make PedsAnesthesia.Net Wiki useful.

Go to the Main Page to see the Topic Outline.

Go to the Generalized Suggested Outline for information on case-specific details for each page.

Go to the Test Page for examples on how to use references in the page.

Malignant Hyperthermia Susceptibility Testing: What's New in 2025?

History of Malignant Hyperthermia

See also Malignant Hypertgermia Association of the United States

Malignant hyperthermia 2020 Guideline from the Association of Anaesthetists

Malignant Hyperthermia Resource Kit

Twitter Thread: Building an MH Cart

Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: a review of past and present practice

Referral Indications for Malignant Hyperthermia Susceptibility Diagnostics in Patients without Adverse Anesthetic Events in the Era of Next-generation Sequencing

Functional analysis of RYR1 variants in patients with confirmed susceptibility to malignant hyperthermia

Fatigue, depression, and physical activity in patients with malignant hyperthermia: a cross-sectional observational study

New device simplifies workstation preparation for malignant hyperthermia-susceptible patients

What is malignant hyperthermia susceptibility?

Real Evidence and Misconceptions about Malignant Hyperthermia in Children: A Narrative Review

Evaluation of Malignant Hyperthermia Features in Patients with Pathogenic or Likely Pathogenic RYR1 Variants Disclosed through a Population Genomic Screening Program

Improving Dantrolene Mobilization in Regions with Limited Availability

The Story Behind the MH Hotline

Propofol binds and inhibits skeletal muscle ryanodine receptor

ASA Monitor Special Issue: Malignant Hyperthermia